5-HT4 receptors in isolated human corpus cavernosum?

International Journal of Impotence Research

Volumn 11, Issue 4, 1999, Pages 219-225

  Hayes, E S ^a   Adaikan, P G ^a   Ratnam, S S ^a   Ng, S C ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Corpus cavernosum; Erectile dysfunction; Prostaglandin E1; SC53116; SDZ250557; Serotonin

Indexed keywords

4 AMINO 5 CHLORO N [(HEXAHYDRO 1H PYRROLIZIN 1 YL)METHYL] 2 METHOXYBENZAMIDE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLIC AMP; GLYCERYL TRINITRATE; ISOPRENALINE; METHYSERGIDE; NORADRENALIN; PINDOLOL; PROSTAGLANDIN E1; SDZ 250557; SEROTONIN 1 RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN 4 ANTAGONIST; SEROTONIN 4 RECEPTOR; SODIUM CHLORIDE; UNCLASSIFIED DRUG; 4 AMINO 5 CHLORO 2 METHOXYBENZOIC ACID 2 (DIETHYLAMINO)ETHYL ESTER; 4 AMINOBENZOIC ACID; BENZAMIDE DERIVATIVE; DRUG DERIVATIVE; PYRROLE DERIVATIVE; SDZ 205-557; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DOSE RESPONSE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION; DRUG EFFECT; MUSCLE RELAXATION; PENIS; PHYSIOLOGY;

4-AMINOBENZOIC ACID; ADRENERGIC BETA-ANTAGONISTS; BENZAMIDES; HUMANS; MALE; METHYSERGIDE; MUSCLE RELAXATION; NOREPINEPHRINE; PENIS; PINDOLOL; PYRROLES; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT4; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0032586658     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3900425     Document Type: Article

References (24)

1. Andersson KE, Wagner G. Physiology of penile erection. Physiol Rev 1995; 75: 191-236.
2. Carrier S, Brock G, Kour NW, Lue TF. Pathophysiology of erectile dysfunction. Urology 1993; 42: 468-481.
3. Lue TF. Physiology of erection and pathophysiology of erectile dysfunction and priapism. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ, (eds). Campbell's Urology. Saunders Company: Philadelphia, 1998, pp 1157-1159.
4. Rosen RS, Leiblum SR. Treatment of sexual disorders in the 1990s: an integrated approach. J Consult Clin Psychol 1995; 63: 877-890.
5. Virag R, Adaikan PG. Effects of prostaglandin E1 on penile erection and erectile failure. J Urol 1987; 137: 1010.
6. Eardley I. New oral therapies for the treatment of erectile dysfunction. Br J Urol 1998; 81: 122-127.
7. Adaikan PG, Ratnam SS. Pharmacology of penile erection in humans. Cardiovosc Intervent Radiol 1988; 11: 191-194.
8. Adaikan PG et al. Neurotransmitters of penile erection other than vasoactive intestinal polypeptide. Physiologic data and therapeutic consequences. J Urol (Paris) 1990; 96: 15-18.
9. Traish AM et al. G-protein-coupled receptor agonists augment adenylyl cyclase activity induced by forskolin in human corpus cavernosum smooth muscle cells. Recept Signal Transduct 1997; 7: 121-132.
10. Christ GJ. The penis as a vascular organ. The importance of corporal smooth muscle tone in the control of erection. Urol Clin North Am 1995; 22: 727-745.
11. Hegde SS, Eglen RM. Peripheral 5-HT4 receptors. FASEB J 1996; 10: 1398-1407.
12. Saudou F, Hen R. 5-hydroxytryptamine receptor subtypes: molecular and functional diversity. Adv Pharmacol 1995; 30: 327-381.
13. Haves ES, Adaikan PG, Arulkumaran S. RSD992 enhances erection and copulation in rats and erection in primates. Int J Impot Res 1996; 8: 189.
14. Hayes ES, Adaikan PG, Ng SC. The effects of 5-HT agonists on central, peripheral and local erectile pathways. Int J Impot Res 1997; 9: S34.
15. Adaikan PG et al. Lack of functional 5-HT4 receptors in human corpus cavernosum. Int J Impot Res 1997; 9 (Suppl): S58.
16. Hayes ES, Adaikan PG, Ng SC. Actions of arylpiperazines on corpus cavernosum smooth muscle in vitro. Asia Pac J Pharmacol 1997; 12: 97-103.
17. Peroutka SJ. 5-Hydroxytryptamine receptors. J Neurochem 1993; 60: 408-416.
18. Hoyer D et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev 1994; 46: 157-203.
19. Schoeffter P, Bobirnac I, Boddeke E, Hoyer D. Inhibition of cAMP accumulation via recombinant human serotonin 5-HT1A receptors: considerations on receptor effector coupling across systems. Neuropharmacology 1997; 36: 429-437.
20. Finberg JP, Vardi Y. Inhibitory effect of 5-hydroxytryptamine on penile erectile function in the rat. Br J Pharmacol 1990; 101: 698-702.
21. Kirkeby HJ, Forman A, Sorensen S, Andersson K-E. Effects of noradrenaline, 5-hydroxytryptamine and histamine on human penile cavernous tissue and circumflex veins. Int J Impot Res 1989; 1: 181-188.
22. McLean PG, Coupar IM, Molenaar P. A comparative study of functional 5-HT4 receptors in human colon, rat oesophagus and rat ileum. Br J Pharmacol 1995; 115: 47-56.
23. Flynn DL et al. SC-53116: the first selective agonist at the newly identified serotonin 5-HT4 receptor subtype. J Med Chem 1992; 35: 1486-1489.
24. Palmer LS et al. Characterization of cyclic AMP accumulation in cultured human corpus cavernosum smooth muscle cells. J Urol 1994; 152: 1308-1314.